Inventor · disambiguated record
Peter L. Toogood
Also filed as: TOOGOOD PETER · TOOGOOD PETER L · TOOGOOD PETER LAURENCE
32 granted patents·12 pending applications·647 citations·filing 1999–2020
97Inventor score
Top patents by PatentIndex Score
44 records- 0197US7208489B22-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-onesWARNER LAMBERT CO·Filed 2005·Granted Apr 24, 2007·92 cites·9 claims
- 0297US6936612B22-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-onesWARNER LAMBERT CO·Filed 2003·Granted Aug 30, 2005·132 cites·2 claims
- 0396US7456168B22-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-onesWARNER LAMBERT CO·Filed 2007·Granted Nov 25, 2008·66 cites·4 claims
- 0494US9394315B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2013·Granted Jul 19, 2016·15 cites·30 claims
- 0594US7863278B2Isethionate salt of a selective CDK4 inhibitorWARNER LAMBERT COMPANYLLC·Filed 2007·Granted Jan 4, 2011·54 cites·4 claims
- 0694US7345171B2Isethionate salt of a selective CKD4 inhibitorWARNER LAMBERT CO·Filed 2004·Granted Mar 18, 2008·103 cites·10 claims
- 0792US9802958B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Oct 31, 2017·7 cites·25 claims
- 0892US9657033B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted May 23, 2017·20 cites·44 claims
- 0992US9266827B2Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted Feb 23, 2016·23 cites·52 claims
- 1091US10208061B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2017·Granted Feb 19, 2019·6 cites·19 claims
- 1190US9512111B2N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseGLICK GARY D·Filed 2011·Granted Dec 6, 2016·21 cites·15 claims
- 1288US8497307B2Aryl guanidine F1F0-ATPase inhibitors and related methodsGLICK GARY D·Filed 2009·Granted Jul 30, 2013·20 cites·26 claims
- 1387US10377768B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Aug 13, 2019·6 cites·28 claims
- 1485US9169199B2Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofHURD ALEXANDER R·Filed 2011·Granted Oct 27, 2015·8 cites·25 claims
- 1585US7557100B2Antibacterial agentsPFIZER·Filed 2006·Granted Jul 7, 2009·8 cites·16 claims
- 1684US9580391B2Saturated acyl guanidine for inhibition of F1F0-ATPaseLYCERA CORP·Filed 2013·Granted Feb 28, 2017·4 cites·30 claims
- 1784US9221814B2Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2013·Granted Dec 29, 2015·8 cites·28 claims
- 1882US7169778B2Pteridinones as kinase inhibitorsWARNER LAMBERT CO·Filed 2000·Granted Jan 30, 2007·15 cites·7 claims
- 1976US8604023B21,4-benzodiazepinone compounds and their use in treating cancerGLICK GARY D·Filed 2010·Granted Dec 10, 2013·2 cites·24 claims
- 2073US10532088B2Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methodsLYCERA CORP·Filed 2015·Granted Jan 14, 2020·2 cites·37 claims
- 2172US7605157B2Tricyclic tetrahydroquinoline antibacterial agentsPHARMACIA & UPJOHN CO LLC·Filed 2007·Granted Oct 20, 2009·1 cites·22 claims
- 2271US9920012B2Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2013·Granted Mar 20, 2018·1 cites·27 claims
- 2369US10112935B2Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Oct 30, 2018·1 cites·32 claims
- 2469US6982260B1Quinazolines and their use for inhibiting cyclin-dependent kinase enzymesWARNER LAMBERT CO·Filed 2000·Granted Jan 3, 2006·5 cites·66 claims
- 2568US7208490B2Tricyclic tetrahydroquinoline antibacterial agentsPHARMACIA & UPJOHN CO LLC·Filed 2003·Granted Apr 24, 2007·4 cites·30 claims
- 2667US6787664B2Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogsWARNER LAMBERT CO·Filed 2003·Granted Sep 7, 2004·4 cites·14 claims
- 2765US7053070B2Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitorsWARNER LAMBERT CO·Filed 2001·Granted May 30, 2006·4 cites·18 claims
- 2865US2010022524A1Tricyclic tetrahydroquinoline antibacterial agentsUPJOHN CO·Filed 2009·Application pending·0 cites
- 2959US2009275536A1Antibacterial AgentsPFIZER·Filed 2009·Application pending·0 cites
- 3058US8952149B2Tricyclic tetrahydroquinoline antibacterial agentsCURTIS MICHAEL·Filed 2013·Granted Feb 10, 2015·0 cites·3 claims
- 3158US7501425B1Bicyclic pyrimidines and bicyclic 3,4-dihydropyprimidines as inhibitors of cellular proliferationWARNER LAMBERT CO·Filed 1999·Granted Mar 10, 2009·15 cites·36 claims
- 3258US2015111884A1Tricyclic tetrahydroquinoline antibacterial agentsZOETIS LLC·Filed 2014·Application pending·0 cites
- 3354US2007049600A1Pteridinones as kinase inhibitorsWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
- 3451US10556898B2Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of diseaseLYCERA CORP·Filed 2019·Granted Feb 11, 2020·0 cites·31 claims
- 3550US8420646B2Tricyclic tetrahydroquinoline antibacterial agentsBARBACHYN MICHAEL ROBERT·Filed 2010·Granted Apr 16, 2013·0 cites·27 claims
- 3647US6974879B2Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogsWARNER LAMBERT CO·Filed 2004·Granted Dec 13, 2005·0 cites·6 claims
- 3747US2022388964A1(aza)indazolyl-aryl sulfonamide and related compounds and their use in treating medical conditionsHIBERCELL INC·Filed 2020·Application pending·0 cites
- 3846US2020207726A1Indolinyl sulfonamide and related compounds for use as agonists of rory and the treatment of diseaseLYCERA CORP·Filed 2019·Application pending·0 cites
- 3944US2005250836A1Inhibitors of checkpoint kinases (Wee1 and Chk1)PFIZER·Filed 2005·Application pending·0 cites
- 4044US2004236084A12-Aminopyridine substituted heterocyclesPFIZER·Filed 2004·Application pending·0 cites
- 4144US2004158065A1Preparation of substituted quinazolinesFiled 2004·Application pending·0 cites
- 4244US2021139484A1Dihydroisoquinoline-2(1h)-carboxamide and related compounds and their use in treating medical conditionsGOSSAMER BIO SERVICES INC·Filed 2019·Application pending·0 cites
- 4343US2006142312A1C6-aryl and heteroaryl substituted pyrido[2,3-D] pyrimidin-7-onesPFIZER·Filed 2004·Application pending·0 cites
- 4441US2004044012A1Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferationFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →